• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前给予低分子肝素可能会降低减重手术后的静脉血栓栓塞症风险。

Adding a Preoperative Dose of LMWH may Decrease VTE Following Bariatric Surgery.

机构信息

Faculty of Medicine, Cairo University, Kasr Al Ainy St., Cairo, 11562, Egypt.

出版信息

World J Surg. 2021 Jan;45(1):126-131. doi: 10.1007/s00268-020-05782-x. Epub 2020 Sep 28.

DOI:10.1007/s00268-020-05782-x
PMID:32989579
Abstract

BACKGROUND

Bariatric procedures are the most effective management for obesity. There is no standard venous thromboembolism (VTE) prophylaxis for both dosing and duration of anticoagulation following laparoscopic sleeve gastrectomy. Our purpose was to assess the optimum regimen for VTE prophylaxis in bariatric procedures and to reduce the incidence of perioperative bleeding.

METHODS AND MATERIALS

This is a prospective randomized study which involved 100 morbidly obese patients, subdivided into two groups; group A received postoperative low molecular weight heparin (LMWH) prophylaxis alone starting from day 1 to day 15 in dose 1 mg/kg/day in a maximum dose 120 mg/day, and group B received both pre- and postoperative LMWH; at night of surgery 12 h preoperatively and postoperative starting from day 1 to day 15 with the same dose. All patients underwent mesenteric and bilateral lower limbs duplex 15 days postoperative using Philips iU machine and linear (L9-3), convex (C5-1) and sector (S5-1) probes.

RESULTS

Regarding postoperative VTE, we found statistically significant increase in postoperative VTE in patients of group A (four cases) without any case complicated with VTE in patients of group B (P value = 0.041). Regarding postoperative bleeding, we found statistically insignificant percent of cases complicated with postoperative bleeding in group B compared to group A (P value 0.315).

CONCLUSION

Preoperative as well as a postoperative prophylactic anticoagulant as LMWH is recommended to prevent perioperative VTE. There was an insignificant increase in postoperative bleeding in patients who received preoperative prophylactic anticoagulants.

摘要

背景

减重手术是肥胖症最有效的治疗方法。腹腔镜袖状胃切除术(LSG)后,抗凝的剂量和持续时间尚无标准的静脉血栓栓塞症(VTE)预防措施。我们的目的是评估减重手术中 VTE 预防的最佳方案,以减少围手术期出血的发生。

方法和材料

这是一项前瞻性随机研究,涉及 100 例病态肥胖患者,分为两组;A 组术后单独使用低分子肝素(LMWH)预防,从第 1 天到第 15 天,剂量为 1mg/kg/天,最大剂量为 120mg/天;B 组在术前和术后使用 LMWH;术前 12 小时夜间手术,术后第 1 天至第 15 天,剂量相同。所有患者术后第 15 天使用飞利浦 iU 机器和线性(L9-3)、凸(C5-1)和扇形(S5-1)探头进行肠系膜和双侧下肢双功超声检查。

结果

关于术后 VTE,我们发现 A 组(4 例)患者术后 VTE 明显增加,而 B 组(P 值=0.041)无患者并发 VTE。关于术后出血,B 组术后出血并发症的比例明显低于 A 组(P 值 0.315)。

结论

建议术前和术后预防性使用抗凝剂(如 LMWH)以预防围手术期 VTE。术前预防性使用抗凝剂的患者术后出血增加不明显。

相似文献

1
Adding a Preoperative Dose of LMWH may Decrease VTE Following Bariatric Surgery.术前给予低分子肝素可能会降低减重手术后的静脉血栓栓塞症风险。
World J Surg. 2021 Jan;45(1):126-131. doi: 10.1007/s00268-020-05782-x. Epub 2020 Sep 28.
2
The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.EFFORT试验:肥胖症手术患者预防血栓形成的术前依诺肝素与术后磺达肝癸钠对比:一项随机双盲试验
Surg Obes Relat Dis. 2015 May-Jun;11(3):672-83. doi: 10.1016/j.soard.2014.10.003. Epub 2014 Oct 23.
3
Prophylactic Use of Enoxaparin in Adolescents During Bariatric Surgery-a Prospective Clinical Study.《肥胖青少年接受减重手术后使用依诺肝素的预防作用:一项前瞻性临床研究》。
Obes Surg. 2020 Jan;30(1):63-68. doi: 10.1007/s11695-019-04135-5.
4
A Single-Center Comparison of Extended and Restricted THROMBOPROPHYLAXIS with LMWH after Metabolic Surgery.代谢手术后 LMWH 延长和限制预防血栓的单中心比较。
Obes Surg. 2020 Feb;30(2):553-559. doi: 10.1007/s11695-019-04188-6.
5
Increased bleeding risk with enoxaparin venothromboembolism prophylaxis compared with heparin in patients undergoing bariatric surgery.与肝素相比,依诺肝素用于肥胖症手术患者的静脉血栓栓塞症预防会增加出血风险。
Surg Endosc. 2023 Sep;37(9):6983-6988. doi: 10.1007/s00464-023-10219-2. Epub 2023 Jun 21.
6
Mandatory Risk Assessment Reduces Venous Thromboembolism in Bariatric Surgery Patients.强制性风险评估可降低肥胖症手术患者的静脉血栓栓塞症发生率。
Obes Surg. 2018 Feb;28(2):541-547. doi: 10.1007/s11695-017-2909-x.
7
Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.髋部骨折手术治疗患者术前抗凝治疗相关静脉血栓栓塞和出血的发生率及安全性研究:一项病例对照研究
BMC Musculoskelet Disord. 2016 Feb 12;17:76. doi: 10.1186/s12891-016-0917-y.
8
Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospective, randomised pilot study evaluating two doses of parnaparin (BAFLUX Study).在减肥手术中使用低分子肝素预防静脉血栓栓塞症:一项前瞻性、随机的初步研究,评估两种那屈肝素钙(BAFLUX 研究)剂量。
Obes Surg. 2014 Feb;24(2):284-91. doi: 10.1007/s11695-013-1105-x.
9
Extended use of bemiparin as thromboprophylaxis during bariatric surgery: results of anti-factor Xa activity measurements.在减重手术期间延长使用贝米肝素作为血栓预防:抗 Xa 因子活性测量的结果。
Surg Obes Relat Dis. 2018 Mar;14(3):354-360. doi: 10.1016/j.soard.2017.12.004. Epub 2017 Dec 14.
10
Is LMWH Sufficient for Anticoagulant Prophylaxis in Bariatric Surgery? Prospective Study.低分子量肝素在减重手术中用于抗凝预防是否足够?前瞻性研究。
Obes Surg. 2017 Sep;27(9):2331-2337. doi: 10.1007/s11695-017-2638-1.

引用本文的文献

1
Portomesenteric Vein Thrombosis Following Sleeve Gastrectomy: A Case Report and Literature Review.袖状胃切除术后门静脉肠系膜静脉血栓形成:一例报告及文献综述
Am J Case Rep. 2025 Sep 3;26:e947151. doi: 10.12659/AJCR.947151.
2
SICOB Italian clinical practice guidelines for the surgical treatment of obesity and associated diseases using GRADE methodology on bariatric and metabolic surgery.《意大利SICOB肥胖症及相关疾病外科治疗临床实践指南》:采用GRADE方法制定的减肥与代谢手术指南
Updates Surg. 2024 Oct 17. doi: 10.1007/s13304-024-01996-z.
3
Association between bariatric surgery preoperative chemoprophylaxis and postoperative bleeding.

本文引用的文献

1
Thirty days are inadequate for assessing readmission following complex hepatopancreatobiliary procedures.30 天不足以评估复杂肝胆胰手术后的再入院情况。
Surg Endosc. 2019 Aug;33(8):2508-2516. doi: 10.1007/s00464-018-6539-8. Epub 2018 Dec 10.
2
Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.肥胖的减肥手术与非手术治疗:随机对照试验的系统评价和荟萃分析。
BMJ. 2013 Oct 22;347:f5934. doi: 10.1136/bmj.f5934.
3
Prevention of venous thromboembolism with enoxaparin in bariatirc surgery.
减肥手术术前化学预防与术后出血之间的关联。
Surg Endosc. 2024 Dec;38(12):7093-7098. doi: 10.1007/s00464-024-11288-7. Epub 2024 Sep 28.
4
30-Day Post-Discharge Prophylaxis with Rivaroxaban Prevents Porto-mesenteric Venous Thrombosis Following Laparoscopic Sleeve Gastrectomy.利伐沙班30天出院后预防可预防腹腔镜袖状胃切除术后门静脉肠系膜静脉血栓形成。
Obes Surg. 2023 Apr;33(4):1026-1031. doi: 10.1007/s11695-023-06471-z. Epub 2023 Jan 27.
5
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.药物干预预防接受减重手术人群的静脉血栓栓塞症。
Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2.
依诺肝素预防肥胖手术患者静脉血栓栓塞症
J Korean Surg Soc. 2013 May;84(5):298-303. doi: 10.4174/jkss.2013.84.5.298. Epub 2013 Apr 24.
4
Pulmonary embolism and deep venous thrombosis following bariatric surgery.肥胖症手术后的肺栓塞和深静脉血栓形成。
Obes Surg. 2013 May;23(5):663-8. doi: 10.1007/s11695-012-0854-2.
5
Metabolic/bariatric surgery worldwide 2011.全球代谢/减重手术 2011 年报告
Obes Surg. 2013 Apr;23(4):427-36. doi: 10.1007/s11695-012-0864-0.
6
Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery.瑞典肥胖受试者(SOS)试验的关键结果回顾-减肥手术的前瞻性对照干预研究。
J Intern Med. 2013 Mar;273(3):219-34. doi: 10.1111/joim.12012. Epub 2013 Feb 8.
7
Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations.不同类型的腹部大手术后,术后静脉血栓栓塞率差异显著。
J Gastrointest Surg. 2008 Nov;12(11):2015-22. doi: 10.1007/s11605-008-0600-1. Epub 2008 Jul 31.
8
A simple venous thromboembolism prophylaxis protocol for patients undergoing bariatric surgery.一种用于接受减肥手术患者的简单静脉血栓栓塞预防方案。
Obesity (Silver Spring). 2006 Nov;14(11):1961-5. doi: 10.1038/oby.2006.229.